The Medicare GLP‑1 Bridge went into effect July 1, 2026. If you qualify, you could access a GLP-1 for as little as a $50 copay.
An estimated
3.8 million Medicare beneficiaries could qualify for the Bridge.
Obesity affects roughly 1 in 4 people on Medicare.
Here's what's changing for coverage.
Starting July 1, 2026, the new Medicare program called the GLP‑1 Bridge opened up temporary coverage for FDA-approved weight loss medication for people enrolled in Medicare Part D who qualify. This program is available through December 31, 2027.
If you were told before that Medicare doesn't cover weight loss medication, it's worth checking again. A new temporary program now covers it for people who qualify.
How Mochi helps
All medication doses available for as little as a $50 co-pay.
Average 12% body weight lost over 1 year1
1In a 72-week trial (ATTAIN-1) of the 36 mg dose in non-diabetic adults with obesity or overweight plus a weight-related condition, with diet and exercise, vs. ~2% for diet and exercise alone. Wharton S, et al. N Engl J Med. 2025;393(18):1796-1806. doi:10.1056/NEJMoa2511774
Foundayo®
Once-daily oral pill, all doses.
Average 19% body weight lost over 1 year2
2In a 68-week trial (STEP UP) of Wegovy HD injection 7.2 mg in non-diabetic adults with obesity, with diet and exercise, vs. ~4% for diet and exercise alone. Wharton S, et al; STEP UP trial group. Lancet Diabetes Endocrinol. 2025;13(11):949-963. doi:10.1016/S2213-8587(25)00226-8
Wegovy® pen
Weekly injection, all doses.
Average 14% body weight lost over 1 year3
3In a 64-week trial (OASIS 4) of Wegovy tablets 25 mg in non-diabetic adults with obesity or overweight plus a weight-related condition, with diet and exercise, vs. ~2% for diet and exercise alone. Wharton S, et al. N Engl J Med. 2025;393(11):1077-1087. doi:10.1056/NEJMoa2500969
Wegovy® tablet
Once-daily oral pill, all doses.
4In a 72-week trial (SURMOUNT-1) of the 15 mg dose in non-diabetic adults with obesity or overweight plus a weight-related condition, with diet and exercise, vs. ~3% for diet and exercise alone. Jastreboff AM, et al. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
Zepbound®
Weekly injection (Kwikpen only), all doses.
FAQ
Everything you need to know
FAQ
01
What is the Medicare GLP‑1 Bridge?
02
How long is the Bridge available?
03
What if I'm not eligible?
Expertise
Choose a board certified obesity medicine provider and a registered dietitian who are ready to work with you to build a plan that fits your history and goals.
400+ board certified
Pricing
Mochi membership brings together provider access, coaching, support, and treatment options in one guided experience.
For iOS & Android
